• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病的起源。

Early life origins of chronic obstructive pulmonary disease.

机构信息

Section of Thoracic Medicine, Institute of Medicine, University of Bergen, Norway.

出版信息

Thorax. 2010 Jan;65(1):14-20. doi: 10.1136/thx.2008.112136. Epub 2009 Sep 2.

DOI:10.1136/thx.2008.112136
PMID:19729360
Abstract

BACKGROUND

Early life development may influence subsequent respiratory morbidity. The impact of factors determined in childhood on adult lung function, decline in lung function and chronic obstructive pulmonary disease (COPD) was investigated.

METHODS

European Community Respiratory Health Survey participants aged 20-45 years randomly selected from general populations in 29 centres underwent spirometry in 1991-3 (n = 13 359) and 9 years later (n = 7738). Associations of early life factors with adult forced expiratory volume in 1 s (FEV(1)), FEV(1) decline and COPD (FEV(1)/FVC ratio <70% and FEV(1) <80% predicted) were analysed with generalised estimating equation models and random effects linear models.

RESULTS

Maternal asthma, paternal asthma, childhood asthma, maternal smoking and childhood respiratory infections were significantly associated with lower FEV(1) and defined as "childhood disadvantage factors"; 40% had one or more childhood disadvantage factors which were associated with lower FEV(1) (men: adjusted difference 95 ml (95% CI 67 to 124); women: adjusted difference 60 ml (95% CI 40 to 80)). FEV(1) decreased with increasing number of childhood disadvantage factors (> or =3 factors, men: 274 ml (95% CI 154 to 395), women: 208 ml (95% CI 124 to 292)). Childhood disadvantage was associated with a larger FEV(1) decline (1 factor: 2.0 ml (95% CI 0.4 to 3.6) per year; 2 factors: 3.8 ml (95% CI 1.0 to 6.6); > or =3 factors: 2.2 ml (95% CI -4.8 to 9.2)). COPD increased with increasing childhood disadvantage (1 factor, men: OR 1.7 (95% CI 1.1 to 2.6), women: OR 1.6 (95% CI 1.01 to 2.6); > or =3 factors, men: OR 6.3 (95% CI 2.4 to 17), women: OR 7.2 (95% CI 2.8 to 19)). These findings were consistent between centres and when subjects with asthma were excluded.

CONCLUSIONS

People with early life disadvantage have permanently lower lung function, no catch-up with age but a slightly larger decline in lung function and a substantially increased COPD risk. The impact of childhood disadvantage was as large as that of heavy smoking. Increased focus on the early life environment may contribute to the prevention of COPD.

摘要

背景

早期生活的发展可能会影响随后的呼吸道发病率。本研究旨在探讨儿童时期确定的因素对成人肺功能、肺功能下降和慢性阻塞性肺疾病(COPD)的影响。

方法

欧洲社区呼吸健康调查在 29 个中心随机选择了年龄在 20-45 岁的普通人群中的参与者,他们在 1991-3 年(n=13359)和 9 年后(n=7738)接受了肺功能检查。采用广义估计方程模型和随机效应线性模型分析了早期生活因素与成人 1 秒用力呼气量(FEV1)、FEV1 下降和 COPD(FEV1/FVC 比值<70%和 FEV1<80%预测值)的相关性。

结果

母亲哮喘、父亲哮喘、儿童哮喘、母亲吸烟和儿童呼吸道感染与较低的 FEV1 显著相关,被定义为“儿童期不利因素”;40%的人有一个或多个儿童期不利因素,与较低的 FEV1 相关(男性:调整差异 95ml(95%CI 67 至 124);女性:调整差异 60ml(95%CI 40 至 80))。随着儿童期不利因素数量的增加(≥3 个因素,男性:274ml(95%CI 154 至 395),女性:208ml(95%CI 124 至 292)),FEV1 下降。儿童期不利因素与较大的 FEV1 下降相关(1 个因素:每年 2.0ml(95%CI 0.4 至 3.6);2 个因素:3.8ml(95%CI 1.0 至 6.6);≥3 个因素:2.2ml(95%CI -4.8 至 9.2))。随着儿童期不利因素的增加,COPD 的风险也随之增加(1 个因素,男性:OR 1.7(95%CI 1.1 至 2.6),女性:OR 1.6(95%CI 1.01 至 2.6);≥3 个因素,男性:OR 6.3(95%CI 2.4 至 17),女性:OR 7.2(95%CI 2.8 至 19))。这些发现在中心之间是一致的,并且当排除哮喘患者时也是一致的。

结论

早期生活不利的人肺功能永久较低,与年龄无关,但肺功能下降略大,COPD 风险显著增加。儿童期不利因素的影响与重度吸烟相当。增加对生命早期环境的关注可能有助于预防 COPD。

相似文献

1
Early life origins of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的起源。
Thorax. 2010 Jan;65(1):14-20. doi: 10.1136/thx.2008.112136. Epub 2009 Sep 2.
2
Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.与性别相关的轻至中度慢性阻塞性肺疾病(COPD)患者肺功能及其下降的预测因素:欧洲慢性阻塞性肺疾病观察性前瞻性队列研究(Euroscop)的结果
Respir Med. 2006 Apr;100(4):746-53. doi: 10.1016/j.rmed.2005.08.004. Epub 2005 Sep 30.
3
The association between childhood asthma and adult chronic obstructive pulmonary disease.儿童哮喘与成人慢性阻塞性肺疾病的关系。
Thorax. 2014 Sep;69(9):805-10. doi: 10.1136/thoraxjnl-2013-204815. Epub 2014 Mar 19.
4
Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.改良版GOLD 1期慢性阻塞性肺疾病患者的肺功能、医疗服务利用情况及生活质量的长期下降
Thorax. 2008 Sep;63(9):768-74. doi: 10.1136/thx.2007.093724. Epub 2008 May 27.
5
The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.瑞典乌普萨拉慢性阻塞性肺疾病的患病率——慢性阻塞性肺病负担(BOLD)研究:基于人群的横断面研究
Clin Respir J. 2012 Apr;6(2):120-7. doi: 10.1111/j.1752-699X.2011.00257.x. Epub 2011 Jul 6.
6
Do childhood respiratory infections continue to influence adult respiratory morbidity?儿童期呼吸道感染是否会持续影响成人的呼吸道发病率?
Eur Respir J. 2009 Feb;33(2):237-44. doi: 10.1183/09031936.00062907. Epub 2008 Nov 14.
7
Childhood asthma and GOLD-defined chronic obstructive pulmonary disease.儿童哮喘与 GOLD 定义的慢性阻塞性肺疾病。
Intern Med J. 2012 Jan;42(1):83-8. doi: 10.1111/j.1445-5994.2010.02238.x. Epub 2010 Apr 12.
8
Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals.短端粒长度、肺功能与 46396 人的慢性阻塞性肺疾病。
Thorax. 2013 May;68(5):429-35. doi: 10.1136/thoraxjnl-2012-202544. Epub 2012 Dec 25.
9
Lower FEV1 in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV1, total IgE levels, and TSLP genotypes.非 COPD、非哮喘受试者的较低 FEV1:与吸烟、FEV1 年下降率、总 IgE 水平和 TSLP 基因型有关。
Int J Chron Obstruct Pulmon Dis. 2011;6:181-9. doi: 10.2147/COPD.S16383. Epub 2011 Mar 2.
10
Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.严重α-1抗胰蛋白酶缺乏症气流阻塞的决定因素
Thorax. 2007 Sep;62(9):806-13. doi: 10.1136/thx.2006.075846. Epub 2007 Mar 27.

引用本文的文献

1
Beyond Smoking: Emerging Drivers of COPD and Their Clinical Implications in Low- and Middle-Income Countries: A Narrative Review.超越吸烟:慢性阻塞性肺疾病的新兴驱动因素及其在低收入和中等收入国家的临床意义:一项叙述性综述
J Clin Med. 2025 Jun 30;14(13):4633. doi: 10.3390/jcm14134633.
2
Towards early detection and disease interception of COPD across the lifespan.实现慢性阻塞性肺疾病(COPD)全生命周期的早期检测与疾病阻断。
Eur Respir Rev. 2025 Jul 9;34(177). doi: 10.1183/16000617.0243-2024. Print 2025 Jul.
3
Importance of Preserved Ratio Impaired Spirometry as a Risk Factor for Development of COPD, Also in Those Who Do Not Smoke.
肺功能测定中存在比值异常作为慢性阻塞性肺疾病(COPD)发生风险因素的重要性,即使在不吸烟者中也是如此。
Chest. 2025 Jul;168(1):83-94. doi: 10.1016/j.chest.2025.02.025. Epub 2025 Mar 8.
4
Childhood respiratory risk profiles associate with lung function and COPD among the old population.儿童期呼吸风险特征与老年人群的肺功能和慢性阻塞性肺疾病相关。
Ann Med. 2025 Dec;57(1):2470954. doi: 10.1080/07853890.2025.2470954. Epub 2025 Feb 26.
5
Heterogeneity of reduced FEV in early adulthood: A looking forward, looking backwards analysis.成年早期用力呼气量降低的异质性:前瞻性与回顾性分析
Respirology. 2025 Apr;30(4):326-334. doi: 10.1111/resp.14876. Epub 2025 Jan 12.
6
Exploring the genetics of airflow limitation in lung function across the lifespan - a polygenic risk score study.探索一生中肺功能气流受限的遗传学——一项多基因风险评分研究。
EClinicalMedicine. 2024 Aug 12;75:102731. doi: 10.1016/j.eclinm.2024.102731. eCollection 2024 Sep.
7
as an Alternative Model to Higher Organisms for In Vivo Lung Research.作为一种替代高等生物的体内肺研究模型。
Int J Mol Sci. 2024 Sep 25;25(19):10324. doi: 10.3390/ijms251910324.
8
Serum Derivatives-Reactive Oxygen Metabolite Levels as a Marker of Clinical Conditions in Patients with Bronchial Asthma, COPD, or Asthma-COPD Overlap: A Prospective Study.血清衍生物反应性氧代谢产物水平作为支气管哮喘、慢性阻塞性肺疾病或哮喘-慢性阻塞性肺疾病重叠患者临床状况的标志物:一项前瞻性研究。
J Clin Med. 2024 Oct 9;13(19):6022. doi: 10.3390/jcm13196022.
9
Air Pollution and Bronchitis: Childhood Exposure, Lifelong Consequences.空气污染与支气管炎:儿童时期的接触,一生的后果。
Am J Respir Crit Care Med. 2024 Oct 15;210(8):973-975. doi: 10.1164/rccm.202407-1278ED.
10
Risk factors of acute exacerbation and disease progression in young patients with COPD.慢性阻塞性肺疾病(COPD)年轻患者急性加重和疾病进展的危险因素
BMJ Open Respir Res. 2024 Jul 17;11(1):e001740. doi: 10.1136/bmjresp-2023-001740.